About
Committees
Get Involved
Clinical Trials
Career Center
Events
Patient Advocacy
KNOW Your State Legislative Tool
Membership
Join MOASC
Renew Your Membership
Sponsors
Newsletter
Healthcare News from PR Newswire
909-985-9061
JOIN OR RENEW NOW
About
Committees
Get Involved
Clinical Trials
Career Center
Events
Patient Advocacy
KNOW Your State Legislative Tool
Membership
Join MOASC
Renew Your Membership
Sponsors
Newsletter
Healthcare News from PR Newswire
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer